Jan-Bernd Stukenborg
Jan-Bernd Stukenborg
NORDFERTIL Research Lab Stockholm, Pediatric Endocrinology Unit, Department of Women’s and Children’s Health, Karolinska Institutet and University Hospital, Stockholm, Sweden
Search for other papers by Jan-Bernd Stukenborg in
Google Scholar
PubMed
Search for other papers by Jan-Bernd Stukenborg in
Google Scholar
PubMed
Kirsi Jahnukainen
Kirsi Jahnukainen
NORDFERTIL Research Lab Stockholm, Pediatric Endocrinology Unit, Department of Women’s and Children’s Health, Karolinska Institutet and University Hospital, Stockholm, Sweden
Division of Haematology-Oncology and Stem Cell Transplantation, Children’s Hospital, University of Helsinki, Helsinki University Central Hospital, Helsinki, Finland
Search for other papers by Kirsi Jahnukainen in
Google Scholar
PubMed
Division of Haematology-Oncology and Stem Cell Transplantation, Children’s Hospital, University of Helsinki, Helsinki University Central Hospital, Helsinki, Finland
Search for other papers by Kirsi Jahnukainen in
Google Scholar
PubMed
Marsida Hutka
Marsida Hutka
MRC Centre for Reproductive Health, The Queen’s Medical Research Institute, The University of Edinburgh, Edinburgh, UK
Search for other papers by Marsida Hutka in
Google Scholar
PubMed
Search for other papers by Marsida Hutka in
Google Scholar
PubMed
Rod T Mitchell
Rod T Mitchell
MRC Centre for Reproductive Health, The Queen’s Medical Research Institute, The University of Edinburgh, Edinburgh, UK
Edinburgh Royal Hospital for Sick Children, Edinburgh, UK
Search for other papers by Rod T Mitchell in
Google Scholar
PubMed
Edinburgh Royal Hospital for Sick Children, Edinburgh, UK
Search for other papers by Rod T Mitchell in
Google Scholar
PubMed
a result of the underlying cancer (e.g. testicular cancer) or due to the damaging effects of chemotherapy or radiotherapy ( 4 ). Treatments that directly damage the SSC population will impact on subsequent fertility; however, indirect effects on germ
Antonella Giampietro
Antonella Giampietro
Pituitary Unit, Department of Endocrinology, Fondazione A Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy
Search for other papers by Antonella Giampietro in
Google Scholar
PubMed
Search for other papers by Antonella Giampietro in
Google Scholar
PubMed
Sabrina Chiloiro
Sabrina Chiloiro
Pituitary Unit, Department of Endocrinology, Fondazione A Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy
Search for other papers by Sabrina Chiloiro in
Google Scholar
PubMed
Search for other papers by Sabrina Chiloiro in
Google Scholar
PubMed
Claudio Urbani
Claudio Urbani
Endocrinology II Unit, Department of Medicine, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
Search for other papers by Claudio Urbani in
Google Scholar
PubMed
Search for other papers by Claudio Urbani in
Google Scholar
PubMed
Rosario Pivonello
Rosario Pivonello
Dipartimento Di Medicina Clinica E Chirurgia, Sezione Di Endocrinologia, Università Federico II di Napoli, Naples, Italy
Search for other papers by Rosario Pivonello in
Google Scholar
PubMed
Search for other papers by Rosario Pivonello in
Google Scholar
PubMed
Martin Ove Carlsson
Martin Ove Carlsson
Global Medical Affairs, Pfizer Rare Disease, Brussels, Belgium
Search for other papers by Martin Ove Carlsson in
Google Scholar
PubMed
Search for other papers by Martin Ove Carlsson in
Google Scholar
PubMed
Francesca Dassie
Francesca Dassie
Department of Medicine - DIMED, University of Padua, Padua, Italy
Search for other papers by Francesca Dassie in
Google Scholar
PubMed
Search for other papers by Francesca Dassie in
Google Scholar
PubMed
Nunzia Prencipe
Nunzia Prencipe
Division of Endocrinology, Diabetology and Metabolism, Department of Medical Science, University of Turin, Turin, Italy
Search for other papers by Nunzia Prencipe in
Google Scholar
PubMed
Search for other papers by Nunzia Prencipe in
Google Scholar
PubMed
Marta Ragonese
Marta Ragonese
Unit of Endocrinology, Department of Human Pathology, University of Messina, Messina, Italy
Search for other papers by Marta Ragonese in
Google Scholar
PubMed
Search for other papers by Marta Ragonese in
Google Scholar
PubMed
Roy Gomez
Roy Gomez
Global Medical Affairs, Pfizer Rare Disease, Brussels, Belgium
Search for other papers by Roy Gomez in
Google Scholar
PubMed
Search for other papers by Roy Gomez in
Google Scholar
PubMed
Simona Granato
Simona Granato
Medical Department, Pfizer Italia, Rome, Italy
Search for other papers by Simona Granato in
Google Scholar
PubMed
Search for other papers by Simona Granato in
Google Scholar
PubMed
Salvatore Cannavò
Salvatore Cannavò
Unit of Endocrinology, Department of Human Pathology, University of Messina, Messina, Italy
Search for other papers by Salvatore Cannavò in
Google Scholar
PubMed
Search for other papers by Salvatore Cannavò in
Google Scholar
PubMed
Silvia Grottoli
Silvia Grottoli
Division of Endocrinology, Diabetology and Metabolism, Department of Medical Science, University of Turin, Turin, Italy
Search for other papers by Silvia Grottoli in
Google Scholar
PubMed
Search for other papers by Silvia Grottoli in
Google Scholar
PubMed
Pietro Maffei
Pietro Maffei
Department of Medicine - DIMED, University of Padua, Padua, Italy
Search for other papers by Pietro Maffei in
Google Scholar
PubMed
Search for other papers by Pietro Maffei in
Google Scholar
PubMed
Annamaria Colao
Annamaria Colao
Dipartimento Di Medicina Clinica E Chirurgia, Sezione Di Endocrinologia, Università Federico II di Napoli, Naples, Italy
Search for other papers by Annamaria Colao in
Google Scholar
PubMed
Search for other papers by Annamaria Colao in
Google Scholar
PubMed
Fausto Bogazzi
Fausto Bogazzi
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
Search for other papers by Fausto Bogazzi in
Google Scholar
PubMed
Search for other papers by Fausto Bogazzi in
Google Scholar
PubMed
Antonio Bianchi
Antonio Bianchi
Pituitary Unit, Department of Endocrinology, Fondazione A Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy
Search for other papers by Antonio Bianchi in
Google Scholar
PubMed
Search for other papers by Antonio Bianchi in
Google Scholar
PubMed
(GH)-secreting pituitary tumor that increases GH and insulin-like growth factor 1 (IGF-1) secretion ( 2 ). The primary aim of the treatment – through neurosurgery, radiotherapy or pharmacological therapy – is to achieve disease control by normalizing
Judith Gebauer
Judith Gebauer
Department of Internal Medicine I, University Hospital Schleswig-Holstein, Luebeck, Germany
Search for other papers by Judith Gebauer in
Google Scholar
PubMed
Search for other papers by Judith Gebauer in
Google Scholar
PubMed
Claire E Higham
Claire E Higham
Department of Endocrinology, Christie Hospital NHS Foundation Trust, University of Manchester, and Manchester Academic Health Science Centre, Manchester, UK
Search for other papers by Claire E Higham in
Google Scholar
PubMed
Search for other papers by Claire E Higham in
Google Scholar
PubMed
specialists. Topics will cover bone health, growth hormone deficiency, the impact of different radiotherapy techniques on the hypothalamic–pituitary axis, risk assessment for second cancers, as well as strategies for international collaboration and different
Deborah Cosentini
Deborah Cosentini
Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, ASST Spedali Civili, Brescia, Italy
Search for other papers by Deborah Cosentini in
Google Scholar
PubMed
Search for other papers by Deborah Cosentini in
Google Scholar
PubMed
Salvatore Grisanti
Salvatore Grisanti
Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, ASST Spedali Civili, Brescia, Italy
Search for other papers by Salvatore Grisanti in
Google Scholar
PubMed
Search for other papers by Salvatore Grisanti in
Google Scholar
PubMed
Alberto Dalla Volta
Alberto Dalla Volta
Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, ASST Spedali Civili, Brescia, Italy
Search for other papers by Alberto Dalla Volta in
Google Scholar
PubMed
Search for other papers by Alberto Dalla Volta in
Google Scholar
PubMed
Marta Laganà
Marta Laganà
Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, ASST Spedali Civili, Brescia, Italy
Search for other papers by Marta Laganà in
Google Scholar
PubMed
Search for other papers by Marta Laganà in
Google Scholar
PubMed
Chiara Fiorentini
Chiara Fiorentini
Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy
Search for other papers by Chiara Fiorentini in
Google Scholar
PubMed
Search for other papers by Chiara Fiorentini in
Google Scholar
PubMed
Paola Perotti
Paola Perotti
Internal Medicine, Department of Clinical and Biological Sciences, San Luigi Hospital, University of Turin, Orbassano, Italy
Search for other papers by Paola Perotti in
Google Scholar
PubMed
Search for other papers by Paola Perotti in
Google Scholar
PubMed
Sandra Sigala
Sandra Sigala
Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy
Search for other papers by Sandra Sigala in
Google Scholar
PubMed
Search for other papers by Sandra Sigala in
Google Scholar
PubMed
Alfredo Berruti
Alfredo Berruti
Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, ASST Spedali Civili, Brescia, Italy
Search for other papers by Alfredo Berruti in
Google Scholar
PubMed
Search for other papers by Alfredo Berruti in
Google Scholar
PubMed
predisposing condition of response to immunotherapy. Moreover, there is an increasing interest in combining chemotherapy, radiotherapy or molecular target therapies with immunotherapy ( 28 , 29 ) and of course also agents inhibiting steroid synthesis may have
C Chiapponi
C Chiapponi
Department of General, Visceral, Cancer and Transplant Surgery, University Hospital of Cologne, Cologne, Germany
Search for other papers by C Chiapponi in
Google Scholar
PubMed
Search for other papers by C Chiapponi in
Google Scholar
PubMed
H Alakus
H Alakus
Department of General, Visceral, Cancer and Transplant Surgery, University Hospital of Cologne, Cologne, Germany
Search for other papers by H Alakus in
Google Scholar
PubMed
Search for other papers by H Alakus in
Google Scholar
PubMed
M Faust
M Faust
Polyclinic for Endocrinology, Diabetes and Preventive Medicine, University Hospital of Cologne, Cologne, Germany
Search for other papers by M Faust in
Google Scholar
PubMed
Search for other papers by M Faust in
Google Scholar
PubMed
A M Schultheis
A M Schultheis
Department of Pathology, University Hospital of Cologne, Cologne, Germany
Search for other papers by A M Schultheis in
Google Scholar
PubMed
Search for other papers by A M Schultheis in
Google Scholar
PubMed
J Rosenbrock
J Rosenbrock
Department of Radiation Therapy, University Hospital of Cologne, Cologne, Germany
Search for other papers by J Rosenbrock in
Google Scholar
PubMed
Search for other papers by J Rosenbrock in
Google Scholar
PubMed
M Schmidt
M Schmidt
Department of Nuclear Medicine, Faculty of Medicine, University Hospital of Cologne, Cologne, Germany
Search for other papers by M Schmidt in
Google Scholar
PubMed
Search for other papers by M Schmidt in
Google Scholar
PubMed
repeated surgery or after R1 removal of metastases, in order to reduce the risk of recurrence. The ETA Guidelines ( 8 ) state that 'although RAI-R thyroid carcinomas are not very sensitive to radiation, external beam radiotherapy (EBRT) may be indicated in
Dan Liang
Dan Liang
Department of Endocrinology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Search for other papers by Dan Liang in
Google Scholar
PubMed
Search for other papers by Dan Liang in
Google Scholar
PubMed
Han Chen
Han Chen
Department of Endocrinology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Search for other papers by Han Chen in
Google Scholar
PubMed
Search for other papers by Han Chen in
Google Scholar
PubMed
Li-Yong Zhong
Li-Yong Zhong
Department of Endocrinology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Search for other papers by Li-Yong Zhong in
Google Scholar
PubMed
Search for other papers by Li-Yong Zhong in
Google Scholar
PubMed
response to chemotherapy or radiotherapy; (ii) the pre-treatment brain images indicating a sellar lesion; and (iii) the completion of the multidisciplinary treatment for iGCT. The exclusion criteria were (i) a history of chromosomal abnormalities or other
Stefan M Constantinescu
Stefan M Constantinescu
Department of Endocrinology and Nutrition, Cliniques Universitaires Saint-Luc, Brussels, Belgium
Search for other papers by Stefan M Constantinescu in
Google Scholar
PubMed
Search for other papers by Stefan M Constantinescu in
Google Scholar
PubMed
Thierry Duprez
Thierry Duprez
Department of Radiology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
Search for other papers by Thierry Duprez in
Google Scholar
PubMed
Search for other papers by Thierry Duprez in
Google Scholar
PubMed
Edward Fomekong
Edward Fomekong
Department of Neurosurgery, Cliniques Universitaires Saint-Luc, Brussels, Belgium
Search for other papers by Edward Fomekong in
Google Scholar
PubMed
Search for other papers by Edward Fomekong in
Google Scholar
PubMed
Christian Raftopoulos
Christian Raftopoulos
Department of Neurosurgery, Cliniques Universitaires Saint-Luc, Brussels, Belgium
Search for other papers by Christian Raftopoulos in
Google Scholar
PubMed
Search for other papers by Christian Raftopoulos in
Google Scholar
PubMed
Orsalia Alexopoulou
Orsalia Alexopoulou
Department of Endocrinology and Nutrition, Cliniques Universitaires Saint-Luc, Brussels, Belgium
Search for other papers by Orsalia Alexopoulou in
Google Scholar
PubMed
Search for other papers by Orsalia Alexopoulou in
Google Scholar
PubMed
Dominique Maiter
Dominique Maiter
Department of Endocrinology and Nutrition, Cliniques Universitaires Saint-Luc, Brussels, Belgium
Search for other papers by Dominique Maiter in
Google Scholar
PubMed
Search for other papers by Dominique Maiter in
Google Scholar
PubMed
treated with conventional fractionated radiotherapy because of contraindications to surgery. The six other patients elected to remain under surveillance because the growth was moderate (mean of 4 mm during the follow-up period) and did not provoke any new
Jung Soo Lim
Jung Soo Lim
Department of Internal Medicine, Institute of Evidence-Based Medicine, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Gangwon-do, South Korea
Search for other papers by Jung Soo Lim in
Google Scholar
PubMed
Search for other papers by Jung Soo Lim in
Google Scholar
PubMed
Seung-Eun Lee
Seung-Eun Lee
Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Gangnam-gu, Seoul, South Korea
Search for other papers by Seung-Eun Lee in
Google Scholar
PubMed
Search for other papers by Seung-Eun Lee in
Google Scholar
PubMed
Jung Hee Kim
Jung Hee Kim
Department of Internal Medicine, Seoul National University College of Medicine, Jongno-gu, Seoul, South Korea
Search for other papers by Jung Hee Kim in
Google Scholar
PubMed
Search for other papers by Jung Hee Kim in
Google Scholar
PubMed
Jae Hyeon Kim
Jae Hyeon Kim
Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Gangnam-gu, Seoul, South Korea
Search for other papers by Jae Hyeon Kim in
Google Scholar
PubMed
Search for other papers by Jae Hyeon Kim in
Google Scholar
PubMed
The Korean Adrenal Gland and Endocrine Hypertension Study Group, Korean Endocrine Society
The Korean Adrenal Gland and Endocrine Hypertension Study Group, Korean Endocrine Society
Search for other papers by The Korean Adrenal Gland and Endocrine Hypertension Study Group, Korean Endocrine Society in
Google Scholar
PubMed
Search for other papers by The Korean Adrenal Gland and Endocrine Hypertension Study Group, Korean Endocrine Society in
Google Scholar
PubMed
included in the survey to determine therapeutic and adverse outcomes in a Korean ACC patient cohort. Although ACC was previously considered a radiotherapy-resistant disease, and there were contradictory results of adjuvant radiotherapy ( 47 , 48 ), recent
Emmanuelle Motte
Emmanuelle Motte
UFR des Sciences de la Santé, Simone Veil, Université Versailles St-Quentin en Yvelines, Montigny le Bretonneux, France
Assistance Publique Hôpitaux de Paris (APHP), Department of Endocrinology and Diabetes for Children, Bicêtre Paris-Sud, Le Kremlin Bicêtre, France
Search for other papers by Emmanuelle Motte in
Google Scholar
PubMed
Assistance Publique Hôpitaux de Paris (APHP), Department of Endocrinology and Diabetes for Children, Bicêtre Paris-Sud, Le Kremlin Bicêtre, France
Search for other papers by Emmanuelle Motte in
Google Scholar
PubMed
Anya Rothenbuhler
Anya Rothenbuhler
Assistance Publique Hôpitaux de Paris (APHP), Department of Endocrinology and Diabetes for Children, Bicêtre Paris-Sud, Le Kremlin Bicêtre, France
APHP, Plateforme d’Expertise Maladies Rares Paris Sud, Bicêtre Paris Sud Hospital, Le Kremlin Bicêtre, France
Search for other papers by Anya Rothenbuhler in
Google Scholar
PubMed
APHP, Plateforme d’Expertise Maladies Rares Paris Sud, Bicêtre Paris Sud Hospital, Le Kremlin Bicêtre, France
Search for other papers by Anya Rothenbuhler in
Google Scholar
PubMed
Stephan Gaillard
Stephan Gaillard
Department of Neurosurgery, Foch Hospital, Suresnes, France
Search for other papers by Stephan Gaillard in
Google Scholar
PubMed
Search for other papers by Stephan Gaillard in
Google Scholar
PubMed
Najiba Lahlou
Najiba Lahlou
APHP, Department of Hormonal Biology, Cochin Hospital, Paris, France
Search for other papers by Najiba Lahlou in
Google Scholar
PubMed
Search for other papers by Najiba Lahlou in
Google Scholar
PubMed
Cécile Teinturier
Cécile Teinturier
Assistance Publique Hôpitaux de Paris (APHP), Department of Endocrinology and Diabetes for Children, Bicêtre Paris-Sud, Le Kremlin Bicêtre, France
APHP, Plateforme d’Expertise Maladies Rares Paris Sud, Bicêtre Paris Sud Hospital, Le Kremlin Bicêtre, France
Search for other papers by Cécile Teinturier in
Google Scholar
PubMed
APHP, Plateforme d’Expertise Maladies Rares Paris Sud, Bicêtre Paris Sud Hospital, Le Kremlin Bicêtre, France
Search for other papers by Cécile Teinturier in
Google Scholar
PubMed
Régis Coutant
Régis Coutant
Department of Pediatric Endocrinology, Angers University Hospital, Angers, France
Search for other papers by Régis Coutant in
Google Scholar
PubMed
Search for other papers by Régis Coutant in
Google Scholar
PubMed
Agnès Linglart
Agnès Linglart
Assistance Publique Hôpitaux de Paris (APHP), Department of Endocrinology and Diabetes for Children, Bicêtre Paris-Sud, Le Kremlin Bicêtre, France
APHP, Plateforme d’Expertise Maladies Rares Paris Sud, Bicêtre Paris Sud Hospital, Le Kremlin Bicêtre, France
Search for other papers by Agnès Linglart in
Google Scholar
PubMed
APHP, Plateforme d’Expertise Maladies Rares Paris Sud, Bicêtre Paris Sud Hospital, Le Kremlin Bicêtre, France
Search for other papers by Agnès Linglart in
Google Scholar
PubMed
, 15 , 16 ), prompting physicians to use alternative therapies such as pituitary radiotherapy or adrenolytic agents. O,p’-dichlorodiphenyldichloroethane (mitotane, Lysodren 500 mg; HRA Pharma, Paris, France) is an adrenolytic drug with a direct
Eva Jakobsson Ung
Eva Jakobsson Ung
Institute of Health and Care Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
Centre for Person-Centred Care (GPCC), University of Gothenburg, Gothenburg, Sweden
Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Eva Jakobsson Ung in
Google Scholar
PubMed
Centre for Person-Centred Care (GPCC), University of Gothenburg, Gothenburg, Sweden
Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Eva Jakobsson Ung in
Google Scholar
PubMed
Ann-Charlotte Olofsson
Ann-Charlotte Olofsson
Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Ann-Charlotte Olofsson in
Google Scholar
PubMed
Search for other papers by Ann-Charlotte Olofsson in
Google Scholar
PubMed
Ida Björkman
Ida Björkman
Institute of Health and Care Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
Centre for Person-Centred Care (GPCC), University of Gothenburg, Gothenburg, Sweden
Search for other papers by Ida Björkman in
Google Scholar
PubMed
Centre for Person-Centred Care (GPCC), University of Gothenburg, Gothenburg, Sweden
Search for other papers by Ida Björkman in
Google Scholar
PubMed
Tobias Hallén
Tobias Hallén
Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden
Institute of Neuroscience and Physiology, University of Gothenburg, Sahlgrenska Academy, Gothenburg, Sweden
Search for other papers by Tobias Hallén in
Google Scholar
PubMed
Institute of Neuroscience and Physiology, University of Gothenburg, Sahlgrenska Academy, Gothenburg, Sweden
Search for other papers by Tobias Hallén in
Google Scholar
PubMed
Daniel S Olsson
Daniel S Olsson
Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Daniel S Olsson in
Google Scholar
PubMed
Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Daniel S Olsson in
Google Scholar
PubMed
Oskar Ragnarsson
Oskar Ragnarsson
Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Oskar Ragnarsson in
Google Scholar
PubMed
Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Oskar Ragnarsson in
Google Scholar
PubMed
Thomas Skoglund
Thomas Skoglund
Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden
Institute of Neuroscience and Physiology, University of Gothenburg, Sahlgrenska Academy, Gothenburg, Sweden
Search for other papers by Thomas Skoglund in
Google Scholar
PubMed
Institute of Neuroscience and Physiology, University of Gothenburg, Sahlgrenska Academy, Gothenburg, Sweden
Search for other papers by Thomas Skoglund in
Google Scholar
PubMed
Sofie Jakobsson
Sofie Jakobsson
Institute of Health and Care Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
Centre for Person-Centred Care (GPCC), University of Gothenburg, Gothenburg, Sweden
Search for other papers by Sofie Jakobsson in
Google Scholar
PubMed
Centre for Person-Centred Care (GPCC), University of Gothenburg, Gothenburg, Sweden
Search for other papers by Sofie Jakobsson in
Google Scholar
PubMed
Gudmundur Johannsson
Gudmundur Johannsson
Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Gudmundur Johannsson in
Google Scholar
PubMed
Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Gudmundur Johannsson in
Google Scholar
PubMed
also, sometimes, radiotherapy ( 4 , 5 ). The tumours and/or its treatment are associated with excess mortality and morbidity ( 3 , 6 , 7 , 8 , 9 ). The consequences of both the tumour and surgery and/or radiotherapy may lead to hypopituitarism and
